AI Chronic Disease Prevention Market Size 2026–2035The Global AI Chronic Disease Prevention Market is expected to reach a value of USD 30.2 billion in 2026, and it is further anticipated to reach USD 488.4 billion by 2035, growing at a CAGR of 36.2% during the forecast period.The AI Chronic Disease Prevention Market is expanding as healthcare providers increasingly adopt artificial intelligence for early risk identification, predictive analytics, and personalized disease prevention. Growing prevalence of chronic conditions, rising healthcare costs, and increasing availability of patient data are driving demand for AI-enabled prevention solutions. AI technologies are helping healthcare organizations analyze health data, identify high-risk patients, and support proactive interventions.The market is further supported by advancements in machine learning, remote patient monitoring, wearable devices, and digital health platforms. Integration of AI with preventive healthcare programs is improving patient monitoring and enabling more personalized care strategies. Growing investments in healthcare technology and the adoption of data-driven clinical decision-making are expected to create new opportunities for market growth.FULL REPORT - https://dimensionmarketresearch.com/report/ai-chronic-disease-prevention-market/